USPTO serial 86299032
ONCOZENE
Reviewed by CopyMark Law Group
Reg. 4754541Status 710
- Filing date
- Status date
- Registration date
- Jun 16, 2015
- Examiner
- STEIN, JAMES W
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with ONCOZENE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
San Antonio, TX
San Antonio, TX
San Antonio, TX
HAMILTON, BM
PALO ALTO, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Kelly P. McCarthy
Kelly P. McCarthy Sideman & Bancroft LLPOne Embarcadero Center, 22nd FloorSan Francisco, CA 94111UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 010 | Medical products, namely, embolic microspheres for use in endovascular therapy, for treatment of hypervascularized tumors and to control and prevent abnormal bleeding; Medical products, namely, embolic microspheres for embolization in the form of particles; Medical products, namely, embolic microspheres in the form of particles to slow or block blood flow for mediating devascularizations; Medical products, namely, embolic microspheres in the form of particles to block blood flow throughout the vasculature system; Medical products, namely, embolic microspheres in the form of particles to treat hemorrhages, arteriovenous malformations, hemangioendothelioma, cerebral aneurysms, muscle hypertrophy, hypertrophic cardiomyopathy, gastrointestinal bleeding, trauma, epistaxis, bone cysts, bone metastases, vertebral metastases, varicoceles, congenital hemangioma, artiovenous fistulae, vena cava, vascular anomalies, priapism, prostatic hematuria, hemoptysis, hemorrhagic cystitis, and post-partum hemorrhage; Medical products, namely, embolic microspheres in the form of particles to prevent or reduce blood flow through any tissue or organ of interest in order to reduce the growths of hypervascular tissues or malignant cells, tumors, lesions, hepatocellular carcinoma, and fibroids; Medical products, namely, embolic microspheres in the form of particles to treat vascular conditions; Medical products, namely, embolic microspheres in the form of embolic particle implants; Medical products, namely, embolic microspheres for treating vascular anomalies of the body | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by CELONOVA BIOSCIENCES, INC.
- Other trademarks owned by CELONOVA BIOSCIENCES, INC.
- Other trademarks owned by CELONOVA BIOSCIENCES, INC.
- Other trademarks owned by BOSTON SCIENTIFIC LIMITED
- Other trademarks owned by VARIAN MEDICAL SYSTEMS, INC.
- Other trademarks in Class 010
- Similar marks named ONCOZENE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 17, 2021 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Jun 16, 2020 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Feb 5, 2020 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Nov 6, 2019 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 6, 2019 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 27, 2016 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 27, 2016 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 27, 2016 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Jun 16, 2015 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 31, 2015 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 31, 2015 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 11, 2015 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 20, 2015 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Feb 12, 2015 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 12, 2015 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Feb 12, 2015 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Feb 12, 2015 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Feb 12, 2015 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Feb 11, 2015 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 11, 2015 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 2, 2015 | ALIE | ASSIGNED TO LIE | — |
| Jan 23, 2015 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 7, 2014 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 7, 2014 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 7, 2014 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 7, 2014 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 17, 2014 | MDSM | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Jun 16, 2014 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 6, 2014 | NWAP | NEW APPLICATION ENTERED | — |